Cypress Systems Supplying Product to NCI Trial

Cypress Systems Supplying Product to NCI Trial

TUCSON, Ariz.--The Arizona Cancer Center, aNational Cancer Institute (NCI)-designated comprehensive cancer center at theUniversity of Arizona, is recruiting participants for a study examining the roleof a pharmaceutical and/or selenium in the prevention of colon cancer. Thethree-year study will involve participants in Arizona and Colorado.

Under terms of a clinical trial agreement signed in early 2000between NCI and Cypress Systems Inc., the new study will use Cypress'SelenoExcell High Selenium Yeast product as the selenium source. AnNCI-sponsored study still in progress at Beth Israel Deconess Medical Center inBoston is also reviewing the ability of selenium to reduce the risk of lungcancer.

For more information on SelenoExcell, visit www.cypsystems.comor Booth #1879 at SupplySide West.